Mandate

Vinge advises Active Biotech on rights offering

February 15, 2018 Capital Markets and Public M&A

Active Biotech AB (publ) issues new shares with pre-emptive rights for the shareholders.

The Vinge team includes Erik Sjöman, Christian Lindhé, Astrid Karlsson and Jack Bengtsson.
 

Related

Vinge advises Acrinova in connection with the sale of properties

Vinge advises Acrinova AB (publ) in connection with its sale of properties with an underlying property value of SEK 1.4 billion.
April 15, 2025

Vinge has advised Visa in connection with its investment in Mynt AB

Vinge has advised Visa in connection with its investment in the Swedish fintech company Mynt AB ("Mynt"). The investment, which is part of Mynt's announced Series B funding round, underscores Visa's commitment to supporting innovative fintech solutions and improving payment experiences for businesses across Europe.
April 14, 2025

Vinge advises Scania on its acquisition of Northvolt’s Systems Industrial business

Vinge advises Scania on its acquisition of Northvolt’s Systems Industrial business, including production capabilities, a research and development center, and a team of approximately 260 employees. The operations are based in two locations: a production facility in Gdańsk, Poland, and an R&D center in Tomteboda, Stockholm, Sweden.
April 11, 2025